Publications by authors named "Michel Pletschette"

Claim this Profile
T
The second national anti-tuberculosis drug resistance survey in Tanzania, 2017-2018.
Beatrice Kemilembe Mutayoba, Julia Ershova, Eligius Lyamuya, Michael Hoelscher, Norbert Heinrich, Michel Pletschette

Trop Med Int Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic pulmonary tuberculosis: A rare form of an ancient disease.
Luong Dinh Van, Huy Ngoc Le, Michel Pletschette, Anh Tuan Nguyen, Thinh Hoang Nguyen

Respirol Case Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.
Beatrice Kemilembe Mutayoba, Michael Hoelscher, Norbert Heinrich, Moses L Joloba, Eligius Lyamuya, Michel Pletschette

BMC Genomics· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole genome sequencing-based drug resistance predictions of multidrug-resistant isolates from Tanzania.
Peter M Mbelele, Christian Utpatel, Elingarami Sauli, Emmanuel A Mpolya, Beatrice K Mutayoba, Michel Pletschette

JAC Antimicrob Resist· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).
Katja Radon, Abhishek Bakuli, Peter Pütz, Ronan Le Gleut, Jessica Michelle Guggenbuehl Noller, Michel Pletschette

BMC Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.
Michael Pritsch, Katja Radon, Abhishek Bakuli, Ronan Le Gleut, Laura Olbrich, Michel Pletschette

Int J Environ Res Public Health· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from the COVID-19 Pandemic-Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.
Giuseppe Ippolito, Francesco Nicola Lauria, Franco Locatelli, Nicola Magrini, Chiara Montaldo, Michel Pletschette

Int J Infect Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials.
Simone Lanini, John P A Ioannidis, Francesco Vairo, Michel Pletschette, Gina Portella

Lancet Infect Dis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Criteria for discharge of patients with Ebola virus diseases in high-income countries.
Nazario Bevilacqua, Emanuele Nicastri, Pierangelo Chinello, Vicenzo Puro, Nicola Petrosillo, Michel Pletschette

Lancet Glob Health· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?
Simone Lanini, Alimuddin Zumla, John P A Ioannidis, Antonino Di Caro, Sanjeev Krishna, Michel Pletschette

Lancet Infect Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-resistant tuberculosis: time for visionary political leadership.
Ibrahim Abubakar, Matteo Zignol, Dennis Falzon, Mario Raviglione, Lucica Ditiu, Michel Pletschette

Lancet Infect Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts.
Ben J Marais, Knut Lönnroth, Stephen D Lawn, Giovanni Battista Migliori, Peter Mwaba, Michel Pletschette

Lancet Infect Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and assessment of criteria to select projects for funding in the EU health programme.
Stephan Van den Broucke, Guy Dargent, Michel Pletschette

Eur J Public Health· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative trial designs are practical solutions for improving the treatment of tuberculosis.
Patrick P J Phillips, Stephen H Gillespie, Martin Boeree, Norbert Heinrich, Rob Aarnoutse, Michel Pletschette

J Infect Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
Alimuddin Zumla, Ibrahim Abubakar, Mario Raviglione, Michael Hoelscher, Lucica Ditiu, Michel Pletschette

J Infect Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities.
Ruth McNerney, Markus Maeurer, Ibrahim Abubakar, Ben Marais, Timothy D McHugh, Michel Pletschette

J Infect Dis· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug resistance and fitness in Mycobacterium tuberculosis infection.
Erik C Bottger, Michel Pletschette, Dan Andersson

J Infect Dis· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Tuberculosis research: an end to neglect and negligence.
Michel Pletschette, Shamila Nair

Trop Med Int Health· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fitness cost of chromosomal drug resistance-conferring mutations.
Peter Sander, Burkhard Springer, Therdsak Prammananan, Antje Sturmfels, Martin Kappler, Michel Pletschette

Antimicrob Agents Chemother· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis